The markets surged to close sharply higher with the Dow rocketing 205 points to 15,373 as lawmakers prepared to vote on a deal to avert a default. Nasdaq leaped 45 points to 3839.
On the upside
A Seeking Alpha contributor suggested that test results indicated that Keryx Biopharmaceuticals' (Nasdaq: KERX) Zerenex may be used to treat anemia in patients with chronic kidney disease.
SolarCity (Nasdaq: SCTY) priced its offering of 3.4 million common shares at the discounted price of $46.54 and priced its $200 million senior notes offering.
Abbott Laboratories (NYSE: ABT) reported lower third quarter earnings but the results topped analyst estimates.
On the downside
Investors locked in profits on VisionChina Media (Nasdaq: VISN).
Elie Mae (NYSE: ELLI) reported in its September Origination Insight Report that the percentage of adjustable rate loans more than doubled from last year.
Morgan Stanley downgraded Arch Coal (NYSE: ACI) from an Equal Weight rating to an Underweight rating.
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 surged 23 points to 1721.
